Teva Animal Health Expands Ketamine Recall

Ketamine recall expanded by Teva Animal Health.

Teva Animal Health Inc. of St. Joseph, Mo., has expanded a nationwide voluntary recall of Ketamine Hydrochloride Injection, USP CIII 100 mg/mL in 10 mL vials due to “serious adverse events” associated with the product, including lack of effect, prolonged effect and death.

The recall now includes all lot numbers within their expiration dates to the veterinary level. Previously, the recall had been limited to the distributor level.

The U.S. Food and Drug Administration, which reported the expanded recall on Dec. 21, is instructing veterinarians who have this product in their possession to cease using the product immediately and return it to their distributor.

Questions can be directed to 800-7593664 from 8 a.m. – 5 p.m. CST, Monday – Friday.


Leave a Comment


Your email address will not be published. Required fields are marked *


Sign-up for your account with Veterinary Practice News. Your account gives you unlimited free access to our Newsletter Archives and our Digital Editions of Veterinary Practice News.
Please check the box below to confirm you would like to be added to Kenilworth Media’s various e-mail communications (includes e-newsletters, a survey now and then, and offers to the veterinarian industry*).

Leave this empty:

*We do not sell your e-mail address to 3rd parties, we simply forward their offers to you. Of course, you always have the right to unsubscribe from any communications you receive from us, should you change your mind in the future.